Fmr LLC Protagonist Therapeutics, Inc Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Fmr LLC holds 434,459 shares of PTGX stock, worth $20 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

434,459

Previous 466,085 6.79%

Holding current value

$20 Million

Previous $13.5 Million 11.65%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$24.66 - $34.8 $779,897 - $1.1 Million	-31,626 Reduced 6.79%	434,459 $15.1 Million
Q1 2024 May 13, 2024	BUY	$21.79 - $32.15 $2,898 - $4,275	133 Added 0.03%	466,085 $13.5 Million
Q4 2023 Feb 13, 2024	SELL	$14.05 - $23.44 $608,224 - $1.01 Million	-43,290 Reduced 8.5%	465,952 $10.7 Million
Q3 2023 Nov 13, 2023	BUY	$16.68 - $23.66 $30,607 - $43,416	1,835 Added 0.36%	509,242 $8.49 Million
Q2 2023 Aug 11, 2023	BUY	$18.02 - $29.36 $8.27 Million - $13.5 Million	459,087 Added 950.1%	507,407 $14 Million
Q1 2023 May 11, 2023	SELL	$10.78 - $25.38 $217,820 - $512,828	-20,206 Reduced 29.49%	48,320 $1.11 Million
Q4 2022 Feb 13, 2023	SELL	$7.36 - $11.17 $20.2 Million - $30.6 Million	-2,740,282 Reduced 97.56%	68,526 $747,000
Q3 2022 Nov 10, 2022	SELL	$7.86 - $11.71 $5.36 Million - $7.99 Million	-682,198 Reduced 19.54%	2,808,808 $23.7 Million
Q2 2022 Aug 12, 2022	SELL	$7.06 - $25.52 $25.7 Million - $92.8 Million	-3,637,573 Reduced 51.03%	3,491,006 $27.6 Million
Q1 2022 May 13, 2022	BUY	$23.34 - $36.08 $6.57 Million - $10.1 Million	281,302 Added 4.11%	7,128,579 $169 Million
Q4 2021 Feb 14, 2022	BUY	$17.63 - $37.1 $6.25 Million - $13.2 Million	354,639 Added 5.46%	6,847,277 $234 Million
Q3 2021 Nov 15, 2021	SELL	$12.95 - $49.69 $8.08 Million - $31 Million	-623,745 Reduced 8.76%	6,492,638 $115 Million
Q2 2021 Aug 13, 2021	BUY	$25.57 - $44.88 $182 Million - $319 Million	7,116,383 New	7,116,383 $319 Million

Others Institutions Holding PTGX

# of Institutions

195

Shares Held

58.7M

Call Options Held

20.8K

Put Options Held

109K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account